Lepios Solutions Launches Sales of the Clarius HD3 Series in Aesthetic Medicine and Plastic Surgery in Japan
Lepios Solutions LLC is pleased to announce that, as of July 1, 2026, it has begun selling the Clarius HD3 Series of wireless ultrasound scanners, manufactured by Clarius Mobile Health of Vancouver, Canada, in the fields of aesthetic dermatology, aesthetic plastic surgery, and plastic surgery in Japan.
This initiative aims to further expand the adoption of Clarius products in the Japanese market and to provide more specialized service to the aesthetic medicine field. Lepios Solutions is the exclusive distributor in Japan for aesthetic dermatology and aesthetic plastic surgery.
About Clarius Mobile Health
Clarius Mobile Health is a manufacturer specializing in wireless ultrasound systems, headquartered in Vancouver, Canada. Its products are sold in more than 70 countries.
About the Clarius HD3 Series
The Clarius HD3 Series consists of wireless ultrasound scanners that display images on a smartphone or tablet. The lineup includes seven scanner types, including convex, linear, phased array, and endocavitary models. The series features the Clarius Intelligence AI platform, which includes T-Mode™, an educational feature that displays anatomical structures on the image in color; Auto Preset AI, which adjusts imaging settings according to the area being scanned; and Voice Controls, which allow operations such as saving images by voice.
Our Commitment
Beyond product sales, we will provide ongoing education through hands-on seminars, webinars, case review meetings, workshops and seminars led by experts from Japan and abroad, and information on clinical use.
We appreciate your continued support.
Overview
Product: Clarius HD3 Series (wireless ultrasound scanners)
Manufacturer: Clarius Mobile Health (Vancouver, Canada)
Sales start date: July 1, 2026
Our sales fields:
Aesthetic dermatology and aesthetic plastic surgery (exclusive distributor in Japan)
Plastic surgery
Product InquiriesLepios Solutions LLC, Medical Solutions DivisionE-mail:
Comments